Parkin counteracts symptoms in a Drosophila model of Parkinson's disease

BMC Neuroscience

Volumn 5, Issue , 2004, Pages

  Haywood, Annika F M ^a   Staveley, Brian E ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; PARKIN; PROTEASOME; UBIQUITIN PROTEIN LIGASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; CLIMBING; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DROSOPHILA; ENHANCER REGION; FEMALE; GENE MUTATION; GENETIC MODEL; MALE; MOTOR CONTROL; NERVE CELL DEGENERATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REVIEW; SYMPTOMATOLOGY; TRANSGENE; UPREGULATION;

EID: 2642516493     PISSN: 14712202     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2202-5-14     Document Type: Review

References (62)

1. Parkinson J (ed.). An essay on the Shaking Palsy, 2 edn. Philadelphia: Blakiston; 1817.
2. Spacey SD, Wood NW: The genetics of Parkinson's disease. Curr Opin Neruol 1999, 12:427-432.
3. Dawson TM: New Animal Models for Parkinson's Disease. Cell 2000, 101:115-118.
4. Giasson BI, Lee VM: Parkin and the molecular pathways of Parkinson's disease. Neuron 2001, 31:885-8.
5. Lansbury PT Jr, Brice A: Genetics of Parkinson's disease and biochemical studies of implicated gene products. Curr Opin Cell Biol 2002, 14:653-60.
6. de Silva HR, Khan NL, Wood NW: The genetics of Parkinson's disease. Curr Opin Genet Dev 2000, 10:292-8.
7. Mizuno Y, Hattori N, Mori H, Suzuki T, Tanaka K: Parkin and Parkinson's disease. Curr Opin Neurol 2001, 14:477-82.
8. Polymeropoulos MH, Higgins JJ, Golbe LI, Nussbaum RL: Mapping of a gene for Parkinson's disease to chromosome 4q21-q23. Science 1996, 274:1197-1198.
9. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein R, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Ioria G, Golbe LI, Nussbaum RL: Mutation in the alpha-Synuclein Gene Identified in Families with Parkinson's Disease. Science 1997, 276:2045-2047.
10. Jakes R, Spillantini MG, Goedert M: Identification of two distinct synucleins from human brain. FEBS Letters 1994, 345:27-32.
11. Clayton DF, George JM: The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. Trends Neurosci 1998, 21:249-254.
12. Perez RG, Waymire JC, Lin E, Liu JJ, Guo F, Zigmond MJ: A role for alpha-synuclein in the regulation of dopamine biosynthesis. J Neurosci 2002, 22:3090-9.
13. Baptista MJ, O'Farrell C, Daya S, Ahmad R, Miller DW, Hardy J, Farrer MJ, Cookson MR: Co-ordinate transcriptional regulation of dopamine synthesis genes by alpha-synuclein in human neuroblastoma cell lines. J Neurochem 2003, 85:957-68.
14. Conway KA, Harper JD, Lansbury P: Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease. Nat Med 1998, 4:1318-1320.
15. Conway KA, Harper JD, Lansbury PT: Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid. Biochemistry 2000, 39:2552-2563.
16. Conway KA, Lee SJ, Rochet JC, Ding TT, Williamson RE, Lansbury PT Jr: Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. Proc Natl Acad Sci USA 2000, 97:571-6.
17. Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N: Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998, 392:605-8.
18. Nisipeanu P, Inzelberg R, Blumen SC, Carasso RL, Hattori N, Matsumine H, Mizuno Y: Autosomal-recessive juvenile parkinsonism in a Jewish Yemenite kindred: mutation of Parkin gene. Neurology 1999, 53:1602-1604.
19. Munoz E, Pastor P, Marti MJ, Oliva R, Tolosa E: A new mutation in the parkin gene in a patient with atypical autosomal recessive juvenile parkinsonism. Neurosci Lett 2000, 289:66-8.
20. Ishikawa A, Tsuji S: Clinical analysis of 17 patients in 12 Japanese families with autosomal-recessive type juvenile parkinsonism. Neurology 1996, 47:160-166.
21. Mori H, Kondo T, Yokochi M, Matsumine H, Nakagawa-Hattori Y, Miyake T, Suda K, Mizuno Y: Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q. Neurology 1998, 51:890-2.
22. Hayashi S, Wakabayashi K, Ishikawa A, Nagai H, Saito M, Maruyama M, Takahashi T, Ozawa T, Tsuji S, Takahashi H: An autopsy case of autosomal-recessive juvenile parkinsonism with a homozygous exon 4 deletion in the parkin gene. Mov Disord 2000, 15:884-8.
23. Shimura H, Hattori N, Kubo S, Mizuno Y, Asakawa S, Minoshima S, Shimizu N, Iwai K, Chiba T, Tanaka K, Suzuki T: Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat Gen 2000, 25:302-305.
24. Hershko A, Ciechanover A: The Ubiquitin System. Ann Rev Biochem 1998, 67:425-479.
25. Pickart CM: Mechanisms underlying ubiquitination. Annu Rev Biochem 2001, 70:503-33.
26. Shimura H, Schlossmacher MG, Hattori N, Frosch MP, Trockenbacher A, Schneider R, Mizuno Y, Kosik KS, Selkoe DJ: Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease. Science 2001, 293:263-9.
27. Imai Y, Soda M, Inoue H, Hattori N, Mizuno Y, Takahashi R: An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin. Cell 2001, 105:891-902.
28. Zhang Y, Gao J, Chung KK, Huang H, Dawson VL, Dawson TM: Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proc Natl Acad Sci U S A 2000, 97:13354-9.
29. Chung KK, Zhang Y, Lim KL, Tanaka Y, Huang H, Gao J, Ross CA, Dawson VL, Dawson TM: Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin- 1: implications for Lewy-body formation in Parkinson disease. Nat Med 2001, 7:1144-50.
30. Imai Y, Soda M, Takahashi R: Parkin Suppresses Unfolded Protein Stress-induced Cell Death through Its E3 Ubiquitin-protein Ligase Activity. J Biol Chem 2000, 275:35661-35664.
31. Petrucelli L, O'Farrell C, Lockhart PJ, Baptista M, Kehoe K, Vink L, Choi P, Wolozin B, Farrer M, Hardy J, Cookson MR: Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons. Neuron 2002, 36:1007-19.
32. Feany MB, Bender WW: A Drosophila model of Parkinson's disease. Nature 2000, 404:394-398.
33. Scherzer CR, Jensen RV, Gullans SR, Feany MB: Gene expression changes presage neurodegeneration in a Drosophila model of Parkinson's disease. Hum Mol Genet 2003, 12:2457-66.
34. Pendleton RG, Parvez F, Sayed M, Hillman R: Effects of pharmacological agents upon a transgenic model of Parkinson's disease in Drosophila melanogaster. J Pharmacol Exp Ther 2002, 300:91-6.
35. Auluck PK, Chan HY, Trojanowski JQ, Lee VM, Bonini NM: Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease. Science 2002, 295:865-8.
36. Auluck PK, Bonini NM: Pharmacological prevention of Parkinson disease in Drosophila. Nat Med 2002, 8:1185-6.
37. Yang Y, Nishimura I, Imai Y, Takahashi R, Lu B: Parkin suppresses dopaminergic neuron-selective neurotoxicity induced by Pael-R in Drosophila. Neuron 2003, 37:911-24.
38. Cavener DR: Comparison of the consensus sequence flanking translational start sites in Drosophila and vertebrates. Nucleic Acids Res 1987, 15:1353-61.
39. Moriyama EN, Powell JR: Codon usage bias and tRNA abundance in Drosophila. J Mol Evol 1997, 45:514-23.
40. Greene JC, Whitworth AJ, Kuo I, Andrews LA, Feany MB, Pallanck LJ: Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc Natl Acad Sci U S A 2003, 100:4078-4083.
41. Holt RA, Subramanian GM, Halpern A, Sutton GG, Charlab R, Nusskern DR, Wincker P, Clark AG, Ribeiro JM, Wides R, Salzberg SL, Loftus B, Yandell M, Majoros WH, Rusch DB, Lai Z, Kraft CL, Abril JF, Anthouard V, Arensburger P, Atkinson PW, Baden H, de Berardinis V, Baldwin D, Benes V, Biedler J, Blass C, Bolanos R, Boscus D, Barnstead M, Cai S, Center A, Chaturverdi K, Christophides GK, Chrystal MA, Clamp M, Cravchik A, Curwen V, Dana A, Delcher A, Dew I, Evans CA, Flanigan M, Grundschober-Freimoser A, Friedli L, Gu Z, Guan P, Guigo R, Hillenmeyer ME, Hladun SL, Hogan JR, Hong YS, Hoover J, Jaillon O, Ke Z, Kodira C, Kokoza E, Koutsos A, Letunic I, Levitsky A, Liang Y, Lin JJ, Lobo NF, Lopez JR, Malek JA, McIntosh TC, Meister S, Miller J, Mobarry C, Mongin E, Murphy SD, O'Brochta DA, Pfannkoch C, Qi R, Regier MA, Remington K, Shao H, Sharakhova MV, Sitter CD, Shetty J, Smith TJ, Strong R, Sun J, Thomasova D, Ton LQ, Topalis P, Tu Z, Unger MF, Walenz B, Wang A, Wang J, Wang M, Wang X, Woodford KJ, Wortman JR, Wu M, Yao A, Zdobnov EM, Zhang H, Zhao Q, Zhao S, Zhu SC, Zhimulev I, Coluzzi M, della Torre A, Roth CW, Louis C, Kalush F, Mural RJ, Myers EW, Adams MD, Smith HO, Broder S, Gardner MJ, Fraser CM, Birney E, Bork P, Brey PT, Venter JC, Weissenbach J, Kafatos FC, Collins FH, Hoffman SL: The genome sequence of the malaria mosquito Anopheles gambiae. Science 2002, 298:129-49.
42. Kahle PJ, Leimer U, Haass C: Does failure of parkin-mediated ubiquitination cause juvenile parkinsonism? Trends Biochem Sci 2000, 25:524-7.
43. Freemont PS: RING for destruction? Curr Biol 2000, 10:R84-7.
44. Morett E, Bork P: A novel transactivation domain in parkin. Trends Biochem Sci 1999, 24:229-31.
45. Bae YJ, Park KS, Kang SJ: Genomic organization and expression of parkin in Drosophila melanogaster. Exp Mol Med 2003, 35:393-402.
46. Brand AH, Perrimon N: Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 1993, 118:401-415.
47. Oluwatosin-Chigbu Y, Robbins A, Scott CW, Arriza JL, Reid JD, Zysk JR: Parkin suppresses wild-type alpha-synuclein-induced toxicity in SHSY-5Y cells. Biochem Biophys Res Commun 2003, 309:679-84.
48. Le Bourg E, Lints FA: Hypergravity and aging in Drosophila melanogaster. 4. Climbing activity. Gerontology 1992, 38:59-64.
49. Miquel J, Lundgren PR, Bensch KG, Atlan H: Effects of temperature on the life span, vitality and fine structure of Drosophila melanogaster. Mech Ageing Dev 1976, 5:347-70.
50. Sakata E, Yamaguchi Y, Kurimoto E, Kikuchi J, Yokoyama S, Yamada S, Kawahara H, Yokosawa H, Hattori N, Mizuno Y, Tanaka K, Kato K: Parkin binds the Rpn10 subunit of 26S proteasomes through its ubiquitin-like domain. EMBO Rep 2003, 4:301-6.
51. Tanaka K, Suzuki T, Chiba T, Shimura H, Hattori N, Mizuno Y: Parkin is linked to the ubiquitin pathway. J Mol Med 2001, 79:482-94.
52. Cookson MR, Lockhart PJ, McLendon C, O'Farrell C, Schlossmacher M, Farrer MJ: RING finger 1 mutations in Parkin produce altered localization of the protein. Hum Mol Genet 2003, 12:2957-65.
53. Gu WJ, Corti O, Araujo F, Hampe C, Jacquier S, Lucking CB, Abbas N, Duyckaerts C, Rooney T, Pradier L, Ruberg M, Brice A: The C289G and C418R missense mutations cause rapid sequestration of human Parkin into insoluble aggregates. Neurobiol Dis 2003, 14:357-64.
54. Marin I, Ferrus AP: Comparative genomics of the RBR family, including the Parkinson's disease-related gene parkin and the genes of the ariadne subfamily. Mol Biol Evol 2002, 19:2039-50.
55. BLAST Search [http://flybase.net/blast/]
56. Stapleton M, Carlson J, Brokstein P, Yu C, Champe M, George R, Guarin H, Kronmiller B, Pacleb J, Park S, Wan K, Rubin GM, Celniker SE: A Drosophila full-length cDNA resource. Genome Biol 2002, 3:RESEARCH0080.
57. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ: Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997, 25:3389-402.
58. Pôle Bio-Informatique Lyonnais [http://pbil.univ-lyon1.fr/]
59. Thompson JD, Higgins DG, Gibson TJ: CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994, 22:4673-4680.
60. Li H, Chaney S, Roberts IJ, Forte M, Hirsh J: Ectopic G-protein expression in dopamine and serotonin neurons blocks cocaine sensitization in Drosophila melanogaster. Curr Biol 2000, 10:211-214.
61. Freeman M: Reiterative use of the EGF receptor triggers differentiation of all cell types in the Drosophila eye. Cell 1996, 87:651-60.
62. Staveley BE, Phillips JP, Hilliker AJ: Phenotypic consequences of copper-zinc superoxide dismutase overexpression in Drosophila melanogaster. Genome 1990, 33:867-72.